期刊文献+

复制型重组痘苗活载体疫苗生产工艺研究 被引量:1

Optimization of Production Procedure of Replicating Recombinant Live Vaccinia Virus Vector-based Vaccine
下载PDF
导出
摘要 目的研究复制型重组痘苗活载体疫苗的生产工艺。方法通过在病毒-细胞比(MOI)、不同培养时间、培养温度、碳酸氢钠含量的条件下培养复制型重组痘苗病毒,确定适用于重组痘苗活载体疫苗的生产工艺。以确定的生产工艺制备3批疫苗,并进行各项检定。结果以MOI为1∶750,培养液中加入7.5%碳酸氢钠的比例为1.0%,培养温度为37℃,培养时间为72 h左右,获得疫苗的病毒滴度最高。按此生产工艺生产的3批疫苗,病毒滴度均在107PFU/ml以上,经检定各项指标均合格。结论确定了复制型重组痘苗活载体疫苗的生产工艺。 Objective To optimize the production procedure of replicating recombinant live vaccinia virus vector-based vaccine. Methods Culture replicating recombinant live vaccinia virus vector, in which HIV antigen gene was inserted,at various MOIs, temperatures and sodium bicarbonate concentrations for various hours to optimize the production prrocedure, Throe batches of vaccine were prepared by the optimized procedure for control tests. Results The production procedure was opthnized as follows ;inoculate recombinant virus into ceils at a MOI of 1:750,add 7.5% sodium bicarbonate into medium to a final concentration of 1.0% and incubate at 37℃ for about 72 h. All the 3 batches of vaccines prepared by the procedure reached virus titers of more than 107 PFU/ml and were qualified in control tests. Conclusion The production procedure of replication recombinant live vaccinia virus vector-based vaccine was optimized.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第2期131-132,138,共3页 Chinese Journal of Biologicals
关键词 复制型载体 痘苗病毒 疫苗 生产工艺 Replicating vector Vaccinia virus Vaccine Production procedure
  • 相关文献

参考文献4

二级参考文献13

  • 1杨洁,赖晃文,罗超权,杨太成,徐国恒,王晓怀.人癌胚抗原cDNA-重组痘苗病毒接种动物的研究[J].中山大学学报(医学科学版),1997,17(S1):46-48. 被引量:4
  • 2阮力 汪垣 等.新型疫苗研究的现状与展望[M].北京:科学出版社,1992.171-183.
  • 3陶义训.免疫学和免疫学检验 第2版[M].北京:人民卫生出版社,1999..
  • 4陶义训.免疫学和免疫学检验[M](第2版)[M].北京:人民卫生出版社,1999..
  • 5阮力 汪垣 强伯勤.新型疫苗研究的现状与展望[M].北京:学苑出版社,1992..
  • 6Barre-Sinoussi F, Chermann J C, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome(AIDS) [J ]. Science, 1983, 220: 868-871.
  • 7UNAIDS. AIDS epidemic update [ DB]. http://www. unids. org/epidemic-update, December, 2001.
  • 8Van Baalen C A, Klein M R, Huisman R C, et al. Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type-1 [J]. J Gen Virol, 1996, 77:1659 - 1665.
  • 9Betts M R, Krowka J, Santamaria C, et al. Cross-clade human immunodeficiency virus(HIV)-specific cytotoxic T-lymphcyte responses in HIV-infected Zambians[ J ]. J Virol, 1997, 71:8908- 8911.
  • 10Duradi D, Morvan J, Letourneur F, et al. Cross-reactions between the cytotoxic T lymphocyte responses of human immunodeficiency virus-infected African and European patients[J ]. J Virol, 1998, 72:3547 - 3553.

共引文献11

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部